SMaHT Benchmarking Data
The Somatic Mosaicism across Human Tissues (SMaHT) project is an NIH Common Fund consortium (2023-) aimed at comprehensively characterizing somatic variation (“mosaicism”) in normal human tissues. While most genetic studies have relied on blood-derived DNA, SMaHT captures the full spectrum of DNA variation across cell types, tissues, and organs from phenotypically normal individuals to better understand the role of somatic mosaicism in human development, aging, and disease progression.
Researchers in the consortium develop and apply experimental and computational methods, paired with the state-of-the-art sequencing technologies, to accurately detect even rare mutations (frequency < 1%) in subpopulations of cells. To determine the best experimental and computational approaches for accurate somatic variant detection, SMaHT produces datasets from cell line and tissue homogenate samples to benchmark and develop new technologies and computational tools for mosaic variant detection.
The resulting data include high-coverage whole-genome and transcriptome data using both short-read and long-read sequencing technologies from multiple platforms (e.g., Illumina, PacBio, Oxford Nanopore Technologies, Ultima Genomics). SMaHT will also generate comprehensive genome-wide catalogs of somatic variants. This resource will be valuable not only for researchers studying somatic mosaicism, but also for the broader scientific community interested in large-scale whole-genome sequencing (WGS) data from normal human tissues.
The SMaHT data are available from the SMaHT Data Portal at https://data.smaht.org/ with an overview of the types of data generated at https://data.smaht.org/about/consortium/data. More information about the SMaHT project is at the NIH SMaHT program announcement https://commonfund.nih.gov/smaht, and at the SMaHT project website at https://smaht.org/.
- Type: Cross-Sectional
- Archive: The database of Genotypes and Phenotypes (dbGaP)
